Status:

RECRUITING

HIV-HEART Aging Study

Lead Sponsor:

University Hospital, Essen

Conditions:

HIV Infections

Coronary Disease

Eligibility:

All Genders

18+ years

Brief Summary

The HIV/HEART Aging study (HIVH) is an ongoing, prospective, multicentre trial that was conducted to assess the incidence, the prevalence and the clinical course of cardiovascular diseases (CVD) in HI...

Detailed Description

A comprehensive detailed description of the study procedures had been previously published (European Journal of medical research 2007;12:243-248). Comprehensive non invasive cardiovascular examinatio...

Eligibility Criteria

Inclusion

  • Age \> 18 years
  • Known HIV-infection
  • Signed informed consent

Exclusion

  • Acute cardiovascular disease
  • Unstable hemodynamic status in the three weeks before inclusion
  • Pregnancy

Key Trial Info

Start Date :

May 11 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT04330287

Start Date

May 11 2020

End Date

December 31 2025

Last Update

July 30 2024

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Universitätsklinikum Essen, Klinik für Dermatologie

Essen, Nordrheinwestfalen, Germany, 45147

2

HIV physician pratice

Duisburg, North Rhine-Westphalia, Germany, 47259

3

Institut für Medizinische Informatik, Biometrie und Epidemiologie

Essen, North Rhine-Westphalia, Germany, 45147

4

University Hospital of Bochum, Department of Dermatology

Bochum, Germany, 44791

HIV-HEART Aging Study | DecenTrialz